180 Life Sciences (ATNF) Short Interest Ratio & Short Volume $1.86 -0.08 (-4.12%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends 180 Life Sciences Short Interest Data180 Life Sciences (ATNF) has a short interest of 64,800 shares, representing 13.23% of the float (the number of shares available for trading by the public). This marks a -28.63% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 732,560 shares to cover all short positions.Current Short Interest64,800 sharesPrevious Short Interest90,800 sharesChange Vs. Previous Month-28.63%Dollar Volume Sold Short$144,504.00Short Interest Ratio0.0 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares1,027,000 sharesFloat Size489,900 sharesShort Percent of Float13.23%Today's Trading Volume52,501 sharesAverage Trading Volume732,560 sharesToday's Volume Vs. Average7% Short Selling 180 Life Sciences? Sign up to receive the latest short interest report for 180 Life Sciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartATNF Short Interest Over TimeATNF Days to Cover Over TimeATNF Percentage of Float Shorted Over Time Ad Stansberry Research2025 could be “worse than the dot-com bust”, says man who predicted 2008 banking crisisDan is sharing his latest work with the public. Because what he's tracking right now, he says, is too serious to keep private.Click here to see Dan's full warning to the public. 180 Life Sciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/202464,800 shares $144,504.00 -28.6%13.2%0 $2.23 11/15/202490,800 shares $227,000.00 -34.9%18.5%0 $2.50 10/31/2024139,400 shares $546,448.00 +77.1%28.5%0.1 $3.92 10/15/202478,700 shares $119,624.00 +7.4%16.1%0 $1.52 9/30/202473,300 shares $123,877.00 +21.0%14.1%0.8 $1.69 9/15/202460,600 shares $109,686.00 +78.8%11.7%0.1 $1.81 Get the Latest News and Ratings for ATNF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for 180 Life Sciences and its competitors with MarketBeat's FREE daily newsletter. 8/31/202433,900 shares $61,359.00 +5.3%6.5%0.1 $1.81 8/15/202432,200 shares $60,536.00 -29.7%6.2%0.1 $1.88 7/31/202445,800 shares $95,264.00 -67.5%8.8%0.1 $2.08 7/15/2024140,800 shares $285,824.00 +249.4%27.2%0.2 $2.03 6/30/202440,300 shares $66,495.00 +13.2%7.8%0.1 $1.65 6/15/202435,600 shares $55,180.00 -19.8%6.9%0.3 $1.55 5/31/202444,400 shares $71,928.00 +156.7%8.6%0.3 $1.62 5/15/202417,300 shares $33,562.00 -36.9%3.4%0.1 $1.94 4/30/202427,400 shares $58,910.00 +60.2%5.3%0.3 $2.15 4/15/202417,100 shares $34,542.00 -59.7%3.3%0.2 $2.02 3/31/202442,400 shares $98,792.00 -31.4%8.4%0.4 $2.33 3/15/202461,800 shares $216,300.00 +309.3%12.2%0.6 $3.50 2/29/202415,100 shares $53,152.00 -95.6%3.0%0.2 $3.52 2/15/2024342,100 shares $1.36 million -22.8%3.6%0.3 $3.99 1/31/2024443,300 shares $94,866.20 -61.8%4.6%0.4 $0.21 1/15/20241,160,000 shares $234,552.00 +195.7%12.2%1 $0.20 12/31/2023392,300 shares $83,756.05 -32.9%4.1%0.4 $0.21 12/15/2023584,700 shares $109,923.60 -4.0%6.2%1 $0.19 11/30/2023608,900 shares $165,011.90 +281.3%8.8%1.2 $0.27 11/15/2023159,700 shares $57,476.03 +26.1%2.3%1.2 $0.36 10/31/2023126,700 shares $54,481.00 +21.2%2.3%0.9 $0.43 10/15/2023104,500 shares $58,509.55 -37.3%1.9%0.3 $0.56 9/30/2023166,700 shares $102,103.75 +64.7%3.0%0.5 $0.61 9/15/2023101,200 shares $83,712.64 -30.1%1.8%0.3 $0.83 8/31/2023144,800 shares $96,581.60 -77.1%2.6%0.5 $0.67 8/15/2023632,100 shares $453,847.80 +3,108.6%11.2%1.9 $0.72 7/31/202319,700 shares $18,518.00 -34.8%0.4%0 $0.94 7/15/202330,200 shares $31,408.00 -46.4%0.6%0.1 $1.04 6/30/202356,300 shares $65,871.00 -52.3%1.1%0.1 $1.17 6/15/2023118,000 shares $136,880.00 -27.4%2.4%0.1 $1.16 5/31/2023162,500 shares $185,250.00 +70.3%3.4%0.2 $1.14 5/15/202395,400 shares $98,262.00 -13.2%2.0%0.1 $1.03 4/30/2023109,900 shares $126,385.00 -51.7%2.4%0.2 $1.15 4/15/2023227,500 shares $282,100.00 +106.6%7.2%0.2 $1.24Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad)Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself. 3/31/2023110,100 shares $198,180.00 +56.0%3.5%0.1 $1.80 3/15/202370,600 shares $146,142.00 -59.2%4.6%0 $2.07 2/28/2023173,000 shares $496,510.00 -7.2%11.2%0 $2.87 2/15/2023186,400 shares $561,064.00 -52.7%11.2%0 $3.01 1/31/2023393,900 shares $1.31 million -26.6%23.6%0.1 $3.33 1/15/2023536,900 shares $1.99 million +3.0%32.2%0.1 $3.71 12/30/2022521,100 shares $1.77 million +1,060.6%31.2%0.1 $3.39 12/15/202244,900 shares $243,986.60 -94.9%2.8%0.1 $5.43 11/30/2022874,900 shares $367,458.00 -0.2%N/A4.4 $0.42 11/15/2022876,800 shares $380,881.92 -3.4%N/A4.6 $0.43 10/31/2022907,300 shares $424,797.86 -11.1%N/A4.2 $0.47 10/15/20221,020,000 shares $520,404.00 +1.0%N/A4.9 $0.51 9/30/20221,010,000 shares $671,650.00 +2.0%N/A4.7 $0.67 9/15/2022990,000 shares $801,999.00 -2.0%N/A5.6 $0.81 8/31/20221,010,000 shares $859,914.00 +9.8%N/A4.7 $0.85 8/15/2022919,500 shares $1.05 million -1.7%N/A3.4 $1.14 7/31/2022935,700 shares $1.02 million +3.9%N/A3.3 $1.09 7/15/2022900,500 shares $1.03 million -8.0%N/A2 $1.14 6/30/2022978,400 shares $829,683.20 -13.4%N/A2.1 $0.85 6/15/20221,130,000 shares $998,920.00 -18.7%N/A2.3 $0.88 5/31/20221,390,000 shares $2.25 million -0.7%N/A3.2 $1.62 5/15/20221,400,000 shares $1.76 million +5.3%N/A3.6 $1.26 4/30/20221,330,000 shares $2.82 million -1.5%N/A3.4 $2.12 4/15/20221,350,000 shares $2.65 million -6.3%N/A4.7 $1.96 3/31/20221,440,000 shares $3.73 million -4.0%N/A4.6 $2.59 3/15/20221,500,000 shares $3.87 million +5.6%N/A4.2 $2.58 2/28/20221,420,000 shares $4.53 million -6.6%N/A2.9 $3.19 2/15/20221,520,000 shares $4.97 million +13.4%N/A1.8 $3.27 1/31/20221,340,000 shares $3.83 million -8.8%N/A1.4 $2.86 1/15/20221,470,000 shares $4.47 million -7.0%N/A1.5 $3.04 12/31/20211,580,000 shares $6.16 million -18.1%N/A1.6 $3.90 12/15/20211,930,000 shares $7.86 million +37.9%N/A2 $4.07 11/30/20211,400,000 shares $8.93 million +2.2%N/A1.3 $6.38 11/15/20211,370,000 shares $5.86 million -16.0%N/A1.8 $4.28 10/29/20211,630,000 shares $8.26 million +16.4%N/A2.4 $5.07 10/15/20211,400,000 shares $7.85 million -4.8%N/A1.9 $5.61 9/30/20211,470,000 shares $7.95 million -33.8%N/A2.1 $5.41 9/15/20212,220,000 shares $14.65 million +14.4%N/A3.3 $6.60 8/31/20211,940,000 shares $11.43 million +116.6%N/A3.9 $5.89 8/13/2021895,800 shares $6.96 million -60.5%N/A2 $7.77 7/30/20212,270,000 shares $17.18 million +3.2%20.3%5.7 $7.57 7/15/20212,200,000 shares $20.17 million -0.5%19.7%5.7 $9.17 6/30/20212,210,000 shares $22.10 million -1.3%24.2%1.7 $10.00 6/15/20212,240,000 shares $22.92 million +2.8%24.6%1 $10.23 5/28/20212,180,000 shares $18.62 million -15.5%23.9%0.9 $8.54 5/14/20212,580,000 shares $17.67 million -9.8%28.3%1 $6.85 4/30/20212,860,000 shares $29.66 million -5.6%31.4%1.1 $10.37 4/15/20213,030,000 shares $31.69 million +25.7%33.2%1 $10.46 3/31/20212,410,000 shares $14.80 million +6.2%26.4%0.8 $6.14 3/15/20212,270,000 shares $14.48 million +6.1%83.5%1.3 $6.38Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad)Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself. 2/26/20212,140,000 shares $9.44 million +364.0%78.7%1.3 $4.41 2/12/2021461,200 shares $2.73 million +54.6%17.0%0.3 $5.91 1/29/2021298,300 shares $1.04 million -1.8%11.0%0.2 $3.48 1/15/2021303,900 shares $948,168.00 No Change11.2%0.3 $3.12 ATNF Short Interest - Frequently Asked Questions What is 180 Life Sciences' current short interest? Short interest is the volume of 180 Life Sciences shares that have been sold short but have not yet been closed out or covered. As of November 30th, traders have sold 64,800 shares of ATNF short. 13.23% of 180 Life Sciences' shares are currently sold short. Learn More on 180 Life Sciences' current short interest. What is a good short interest percentage for 180 Life Sciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 13.23% of 180 Life Sciences' floating shares are currently sold short. Is 180 Life Sciences' short interest increasing or decreasing? 180 Life Sciences saw a decline in short interest during the month of November. As of November 30th, there was short interest totaling 64,800 shares, a decline of 28.6% from the previous total of 90,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is 180 Life Sciences' float size? 180 Life Sciences currently has issued a total of 1,027,000 shares. Some of 180 Life Sciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. 180 Life Sciences currently has a public float of 489,900 shares. How does 180 Life Sciences' short interest compare to its competitors? 13.23% of 180 Life Sciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to 180 Life Sciences: NLS Pharmaceutics Ltd. (5.21%), Eyenovia, Inc. (7.25%), Evoke Pharma, Inc. (1.85%), Adial Pharmaceuticals, Inc. (0.79%), GRI Bio, Inc. (1.37%), Trinity Biotech plc (0.64%), Galecto, Inc. (1.79%), ABVC BioPharma, Inc. (2.29%), Moleculin Biotech, Inc. (0.71%), Vincerx Pharma, Inc. (2.19%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short 180 Life Sciences stock? Short selling ATNF is an investing strategy that aims to generate trading profit from 180 Life Sciences as its price is falling. ATNF shares are trading down $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against 180 Life Sciences? A short squeeze for 180 Life Sciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ATNF, which in turn drives the price of the stock up even further. How often is 180 Life Sciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ATNF, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies NLS Pharmaceutics Short Squeeze Eyenovia Short Squeeze Evoke Pharma Short Squeeze Adial Pharmaceuticals Short Squeeze GRI Bio Short Squeeze Trinity Biotech Short Squeeze Galecto Short Squeeze ABVC BioPharma Short Squeeze Moleculin Biotech Short Squeeze Vincerx Pharma Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ATNF) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 180 Life Sciences Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share 180 Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ATNF Stock Alerts